Skip to main content

Table 23 The distribution of plant families and genera used treat each disease and disease category in Peru, Mali, and the combined medicinal flora of the two areas. Those distributions with a significant difference based on a log-likelihood ratio test (G-test) are marked with a footnote, all other pairwise comparisons of categories or diseases are not significantly different.

From: A quantitative synthesis of the medicinal ethnobotany of the Malinké of Mali and the Asháninka of Peru, with a new theoretical framework

  Mali Peru Combined
  Families Genera Families Genera Families Genera
Disease n percent of present n percent of present n percent of present n percent of present n percent of present n percent of present
Parasitic 23 36.51% 38 16.89% 24 12.44% 27 2.37% 35b 17.59% 58cd 4.57%
   Malaria 19 30.16% 32 14.22% 9 4.66% 9 0.79% 25 12.56% 39 3.07%
   Trypanosomesa 13 20.63% 15 6.67% 15 7.77% 18 1.58% 22 11.06% 30 2.36%
Chagas 0 0.00% 0 0.00% 4 2.07% 5 0.44% 4 2.01% 13 1.02%
Leishmaniasis 0 0.00% 0 0.00% 11 5.70% 13 1.14% 11 5.53% 5 0.39%
   Autoimmune 26 41.27% 40 17.78% 28 14.51% 39 3.43% 41 20.60% 75c 5.91%
Diabetes 15 23.81% 19 8.44% 19 9.84% 22 1.93% 32 16.08% 41 3.23%
Asthma 13 20.63% 17 7.56% 12 6.22% 12 1.05% 22 11.06% 28 2.20%
Eczema 17 26.98% 20 8.89% 9 4.66% 10 0.88% 23 11.56% 29 2.28%
   Fibroids 20 31.75% 26 11.56% 12 6.22% 13 1.14% 26b 13.07% 36d 2.83%
  1. a Trypanosomes includes Chagas disease, leishmaniasis, and African sleeping sickness.
  2. b The combined plant families of Peru and Mali used to treat uterine fibroids and parasitic diseases had a significant difference with p = 0.01911
  3. c The combined plant genera of Peru and Mali used to treat autoimmune and parasitic diseases had a significant difference with p = 0.03987
  4. d The combined plant genera of Peru and Mali used to treat uterine fibroids and parasitic diseases had a significant difference with p = 0.04909